Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.

Saved in:
Bibliographic Details
Title: Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Authors: Haraoui B; Institut de Rhumatologie de Montréal, Montreal, Quebec, Canada., Khraishi M; Memorial University of Newfoundland, St. John's, Newfoundland, Canada., Choquette D; Institut de Rhumatologie de Montréal, Montreal, Quebec, Canada., Lisnevskaia L; Oshawa Clinic, Oshawa, Ontario, Canada., Teo M; University of British Columbia, Penticton, British Columbia, Canada., Kinch C; Pfizer Canada ULC, Kirkland, Quebec, Canada., Galos C; Pfizer Canada ULC, Kirkland, Quebec, Canada., Roy P; Pfizer Canada ULC, Kirkland, Quebec, Canada., Gruben D; Pfizer Inc, Groton, Connecticut., Woolcott JC; Pfizer Inc, Collegeville, Pennsylvania., Vaillancourt J; JSS Medical Research, Montreal, Quebec, Canada., Sampalis JS; JSS Medical Research and University of McGill, Montreal, Quebec, Canada., Keystone EC; University of Toronto, Toronto, Ontario, Canada.
Corporate Authors: Canadian Tofacitinib for Rheumatoid Arthritis Observational Investigators
Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2023 Feb; Vol. 75 (2), pp. 240-251. Date of Electronic Publication: 2022 Oct 10.
Publication Type: Observational Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first